Loading…
Based on limited metadata, this FDA Warning Letter issued to Hangzhou Karic Commodities Co., Ltd. on July 31, 2018, involves a company subject to FDA oversight, though the specific product category is listed only as "Other," limiting clarity on the exact regulated product involved. Without access to the full letter text or a documented subject line, the precise nature of the violations cannot be determined from the available information. The issuing office is also not specified in the metadata provided, which further restricts understanding of the regulatory scope and jurisdiction. To fully assess the compliance issues and their regulatory implications, the complete Warning Letter would be necessary.